News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sagent Pharmaceuticals, Inc. Appoints Michael Fekete to Its Board of Directors


7/12/2013 9:24:41 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SCHAUMBURG, Ill., July 11, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that its Board of Directors has expanded the size of the Board from five to six members and appointed Michael Fekete as a Class I Director effective July 10, 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES